Umar Mansuri: Can Micronutrient Powders Help Reduce Childhood Anemia?
Umar Mansuri, Medical Intern at GMERS Medical College – India, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in IJCMPH, adding:
“A Research Milestone – Publication
I’m delighted to share that our review article, ‘Effectiveness of micronutrient powder intervention in reducing anemia among children under six years of age: a rapid review,’ has been published in the International Journal of Community Medicine and Public Health, 2026;13(10):6193–6199.
This rapid review synthesized evidence from 12 studies on the effectiveness of micronutrient powder (MNP) interventions in children under six.
The review found improvements in hemoglobin levels and anemia prevalence, particularly with iron-inclusive formulations and good adherence.
It also highlighted the importance of program delivery and community health-worker involvement.
I would like to extend my heartfelt congratulations and sincere thanks to all my co-authors for their incredible teamwork, dedication and support throughout this journey.
Congratulations to the entire team!
Looking forward to learning more, collaborating with others, and contributing to evidence-based healthcare.”
Title: Effectiveness of micronutrient powder intervention in reducing anemia among children under six years of age: a rapid review
Authors: Mohammed Umar Mansuri, Archi Mehta, Devarsh Vyas, Rudra Trivedi, Shruti Trivedi, Ebbie Thomas

Stay updated with Hemostasis Today.
-
Nov 20, 2026, 17:27Adam Bryant: Great Science, Valuable Connections and a Wonderful Haematology Community at Blood 2026
-
Nov 20, 2026, 17:25Gurpreet Kaurr: Scientific Discussions, New Perspectives and Inspiration at HAEMATOCON 2026
-
Nov 20, 2026, 17:24Bispecific FVIIIa-Mimetic Antibodies in Haemophilia A – CRH French Reference Center for Hemophilia Lyon
-
Nov 20, 2026, 17:23Khalid Rehman: Psychosocial Burden Among Caregivers of Patients with Beta-Thalassemia Major in Pakistan
-
Nov 20, 2026, 17:20Dhinesh Selvaraju: Caplacizumab Becomes the First FDA-Approved Treatment for Pediatric aTTP
-
Nov 20, 2026, 17:19Paris Margaritis: Presenting Preclinical Data on GENV-HEM at the WFH Workshop
-
Nov 20, 2026, 17:18WFH Opens Public Comment on Draft Guidelines for Hemostatic Agents and Prophylaxis
-
Nov 20, 2026, 17:18Ketan Asawale: Consensus on the Management of Cancer-Associated Thrombosis in India
-
Nov 20, 2026, 17:16Ajay Samkaria: The Evolution of Hemostasis Diagnostics with the ACL TOP 70 Series